<DOC>
	<DOCNO>NCT02751762</DOCNO>
	<brief_summary>The purpose study quantify serious risk misuse , abuse , addiction associate long-term use opioid analgesic management chronic pain , among patient prescribe ER/LA opioid product .</brief_summary>
	<brief_title>A Prospective Investigation Risks Opioid Misuse , Abuse , Addiction Among Patients Treated With Extended-release/Long Acting ( ER/LA ) Opioids Treatment Chronic Pain</brief_title>
	<detailed_description>The Food Drug Administration ( FDA ) ask company New Drug Application ( NDA ) holder extended-release/long-acting ( ER/LA ) opioids conduct one study provide quantitative estimate serious risk misuse , abuse , addiction , overdose , death associate long-term use opioid analgesic management chronic pain , among patient prescribe ER/LA opioid product . Although abuse misuse prescription opioids increase past decade , debate magnitude misuse , abuse , addiction among patient treated opioids chronic pain . Further , although appear comorbidity opioid use disorder substance use psychiatric disorder , insufficient data estimate risk outcome varies presence risk factor among patient treated opioids long-term . This study seek fill gap . The primary objective quantify serious risk misuse , abuse , addiction associate long-term use opioid analgesic management chronic pain among patient prescribe ER/LA opioid product . Patients recruit six Health Care System Research Network ( HCSRN ) sit ; one U.S. Department Veterans Affairs ( VA ) site , clinic participate 2 Primary Care Practice-Based Research Network sit . The data source propose study : 1 ) patient report outcomes in-person interview ( phone unavailable participate in-person ) , web-based assessment ( phone unable complete via web ) , electronic medical record claim data . The study design include 2 component : 1 ) A prospective longitudinal study patient recently initiate least 30 day ER/LA opioid therapy , 2 ) A cross-sectional study patient treat opioids ( include least one ER/LA opioid ) great 1 year .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Has 30 day new ER/LA opioid use 2 . Enrolled medical drug benefit least 12 month prior incident use opioids ( HCSRN VA enrollment N/A PBRNs ) 2+ visit participate clinic 12 month prior incident use opioids ( PBRN , HCSRN , VA ) 3 . Additional prescription/ order ER/LA opioid follow least 30 day new use 4 . Ability complete interview/selfadministered questionnaire English 5 . Willing provide inform consent 1 . Not use ER/LA opioid time recruitment ( selfreport ) 2 . Cognitive impairment interfere ability consent participate interview , unavailable 12 month followup , receive hospice care determine time recruitment 3 . Diagnosis terminal illness prior 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>